Baird raised the firm’s price target on AdaptHealth (AHCO) to $16 from $14 and keeps an Outperform rating on the shares. The firm said they posted good Q4 results and a positive 2025 outlook.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHCO:
- AdaptHealth’s Promising Growth: Strong Q4 Results and Strategic Changes Justify Buy Rating
- AdaptHealth price target raised to $14 from $11 at RBC Capital
- AdaptHealth price target raised to $14 from $13 at Canaccord
- AdaptHealth Corp. Reports 2024 Financial Results and 2025 Outlook
- Unusually active option classes on open February 25th
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue